Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2073)
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$4.27
Total Value
$64.05K
Shares Held After
1,169,327
% of Holdings
1.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
398
Price
$1.55
Total Value
$616.90
Shares Held After
72,988
% of Holdings
0.5%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
3,946
Price
$1.55
Total Value
$6.12K
Shares Held After
722,935
% of Holdings
0.5%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
1,233
Price
$34.81
Total Value
$42.93K
Shares Held After
96,412
% of Holdings
1.3%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
2,100
Price
$34.10
Total Value
$71.60K
Shares Held After
97,645
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
386
Price
$549.14
Total Value
$211.97K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,221
Price
$548.21
Total Value
$669.37K
Shares Held After
40,899
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
969
Price
$547.40
Total Value
$530.43K
Shares Held After
42,120
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,124
Price
$546.46
Total Value
$614.22K
Shares Held After
43,089
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$545.00
Total Value
$479.60K
Shares Held After
44,213
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$543.16
Total Value
$282.44K
Shares Held After
45,093
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$542.15
Total Value
$477.09K
Shares Held After
45,613
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
773
Price
$540.92
Total Value
$418.13K
Shares Held After
46,493
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,524
Price
$539.92
Total Value
$822.85K
Shares Held After
47,266
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
818
Price
$539.09
Total Value
$440.97K
Shares Held After
48,790
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
405
Price
$537.58
Total Value
$217.72K
Shares Held After
49,608
% of Holdings
0.8%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
739
Price
$34.06
Total Value
$25.17K
Shares Held After
92,901
% of Holdings
0.8%
GENELUX Corp (GNLX)
Smither John W — Director
Shares
12,000
Price
$2.91
Total Value
$34.90K
Shares Held After
91,403
% of Holdings
11.6%
Hinge Health, Inc. (HNGE)
Mecklenburg Gabriel M.I. — Director
Shares
741
Price
$86.51
Total Value
$64.10K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Mecklenburg Gabriel M.I. — Director
Shares
18,675
Price
$85.75
Total Value
$1.60M
Shares Held After
741
% of Holdings
96.2%
Hinge Health, Inc. (HNGE)
Mecklenburg Gabriel M.I. — Director
Shares
56,518
Price
$85.00
Total Value
$4.80M
Shares Held After
19,416
% of Holdings
74.4%
Hinge Health, Inc. (HNGE)
Mecklenburg Gabriel M.I. — Director
Shares
3,900
Price
$83.95
Total Value
$327.39K
Shares Held After
75,934
% of Holdings
4.9%
Hinge Health, Inc. (HNGE)
Mecklenburg Gabriel M.I. — Director
Shares
3,500
Price
$82.97
Total Value
$290.39K
Shares Held After
79,834
% of Holdings
4.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
2,721
Price
$120.00
Total Value
$326.52K
Shares Held After
3,114
% of Holdings
46.6%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
312
Price
$71.99
Total Value
$22.46K
Shares Held After
490,312
% of Holdings
0.1%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,666
Price
$8.03
Total Value
$133.86K
Shares Held After
1,161,128
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
3,336
Price
$116.56
Total Value
$388.84K
Shares Held After
666,568
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
44,050
Price
$115.69
Total Value
$5.10M
Shares Held After
669,904
% of Holdings
6.2%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
24,105
Price
$114.96
Total Value
$2.77M
Shares Held After
713,954
% of Holdings
3.3%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
6,626
Price
$113.98
Total Value
$755.20K
Shares Held After
738,059
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
1,883
Price
$112.80
Total Value
$212.41K
Shares Held After
744,685
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
3,389
Price
$114.29
Total Value
$387.33K
Shares Held After
47,179
% of Holdings
6.7%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
90,000
Price
$8.03
Total Value
$722.51K
Shares Held After
1,691,126
% of Holdings
5.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
625
Price
$77.21
Total Value
$48.26K
Shares Held After
42,044
% of Holdings
1.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,000
Price
$76.39
Total Value
$76.39K
Shares Held After
42,669
% of Holdings
2.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
2,501
Price
$16.24
Total Value
$40.61K
Shares Held After
135,202
% of Holdings
1.8%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
5,852
Price
$15.67
Total Value
$91.68K
Shares Held After
137,703
% of Holdings
4.1%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$84.92
Total Value
$636.90K
Shares Held After
377,830
% of Holdings
1.9%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
1,112
Price
$87.79
Total Value
$97.62K
Shares Held After
63,221
% of Holdings
1.7%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
69,648
Price
$39.41
Total Value
$2.74M
Shares Held After
24,555
% of Holdings
73.9%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
130,352
Price
$39.41
Total Value
$5.14M
Shares Held After
94,203
% of Holdings
58.0%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,000
Price
$85.80
Total Value
$1.29M
Shares Held After
58,555
% of Holdings
20.4%
ORAMED PHARMACEUTICALS INC. (ORMP)
Gabay Avraham — Chief Financial Officer
Shares
73,360
Price
$4.51
Total Value
$330.74K
Shares Held After
671,785
% of Holdings
9.8%
ORAMED PHARMACEUTICALS INC. (ORMP)
Hexter Joshua — COO & CBO
Shares
137,000
Price
$4.46
Total Value
$611.43K
Shares Held After
1,023,384
% of Holdings
11.8%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,597
Price
$30.44
Total Value
$48.61K
Shares Held After
287,171
% of Holdings
0.6%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
30,311
Price
$29.95
Total Value
$907.92K
Shares Held After
288,768
% of Holdings
9.5%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,593
Price
$29.98
Total Value
$77.73K
Shares Held After
23,337
% of Holdings
10.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
1,200
Price
$30.34
Total Value
$36.40K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
13,409
Price
$29.86
Total Value
$400.46K
Shares Held After
1,200
% of Holdings
91.8%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
240,000
Price
$0.04
Total Value
$10.34K
Shares Held After
94,124,319
% of Holdings
0.3%
Showing 51–100 of 2073 transactions (page 2 of 42)